PrognosDx Health announced that A. Franklin Rice has joined its board of directors. Rice is a member of BayBio Northern California's Life Science Association and "brings a wealth of experience in finance and administration to PrognosDx's board of directors," the company said in a statement.
Rice is currently the chief financial officer of the stem cell-based drug company VistaGen Therapeutics. He has held various positions in the biotech industry for 20 years.
According to documents filed with the US Securities and Exchange Commission, Genomic Health announced that Brook Byers will retire from its board of directors as of June 9. Byers has been a member of Genomic Health's board since 2001.
Byers is a senior partner at Kleiner Perkins Caufield & Byers. Since becoming a venture capital investor in 1972, he as been intimately involved with launching more than fifty technology companies.